This article has been updated with additonal comments from Foundation Medicine's earnings call and from an analyst. 

NEW YORK (GenomeWeb) – Foundation Medicine reported a 13 percent revenue drop for the first quarter after the close of the market on Tuesday, driven by an expected decline in its biopharmaceutical business, while its clinical testing volume picked up considerably.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.